Quadrapax
Product Images NDC 21695-970

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quadrapax (NDC 21695-970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Phenobarbital Structural Formula (6243f28a E7ed 4571 Beb3 2562c5e033c7 01)

FDA Label Image

Hyoscyamine Sulfate Structural Formula (6243f28a E7ed 4571 Beb3 2562c5e033c7 02)

FDA Label Image

Atropine Sulfate Structural Formula (6243f28a E7ed 4571 Beb3 2562c5e033c7 03)

FDA Label Image

Scopolamine Structural Formula (6243f28a E7ed 4571 Beb3 2562c5e033c7 04)

FDA Label Image

Quadrapax 16.2mg/0.10.7mg/0.0194mg/0.0065mg/23% (6243f28a E7ed 4571 Beb3 2562c5e033c7 05)

Quadrapax 16.2mg/0.10.7mg/0.0194mg/0.0065mg/23% (6243f28a E7ed 4571 Beb3 2562c5e033c7 05)
Quadrapax 16.2mg/0.1087mg/0.0184mg/0.0085mg/23% 160z elixir is a medication that contains Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, and Scopolamine Hydrobromide. It is distributed by Acella Pharmaceuticals and is labeled as habit-forming. The provided text contains additional identification information and warnings.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.